Lv3
268 积分 2023-07-08 加入
Second-Generation Dual FXR/sEH Modulators with Optimized Pharmacokinetics
3天前
已完结
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
3天前
已完结
Design and Synthesis of Dual Modulators of Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptors
3天前
已完结
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
3天前
已完结
Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy
3天前
已完结
Nonalcoholic fatty liver disease: The hepatic metabolic syndrome
3天前
已完结
COVID‐19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays
3天前
已完结
Crystal Structure of Inhibitor-Bound Human 5-Lipoxygenase-Activating Protein
3天前
已完结
Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening
3天前
已完结
Preparation of (R)-(+)-N-[3-[5-[(4-Fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitor
3天前
已完结
皖公网安备34019202002308
